How much is Capstan Therapeutics worth in 2026?

Capstan Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Capstan Therapeutics raised?

Capstan Therapeutics has raised N/A in total funding across 3 funding rounds.

Capstan Therapeutics

Biotechnology

Capstan Therapeutics valuation and funding history | Last updated: March 20, 2024 | 3 funding rounds

Current Valuation

N/A

As of March 20, 2024

Total Funding Raised

N/A

Across 3 rounds

Last Round

Early Stage VC (Series B)

$175.0M

Last Funding

Mar 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 20, 2024	Early Stage VC (Series B)	$175.0M	N/A	-
July 15, 2022	Early Stage VC (Series A)	$102.0M	N/A	-
November 1, 2021	Seed Round	$63.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Capstan Therapeutics is currently valued at N/A as of March 20, 2024.

Track Capstan Therapeutics Valuation Updates

Get notified when Capstan Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Capstan Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Capstan Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Capstan Therapeutics Worth in 2026?

Capstan Therapeutics is a leading private company in the Biotechnology sector. Track Capstan Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Capstan Therapeutics Valuation is Determined

Private company valuations like Capstan Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.